Montenegro vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Montenegro
100.0%
in 2023
Sur
82.0%
in 2024
Montenegro rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Montenegro
- Sur
How they compare
Montenegro currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Montenegro's figure about 1.2 times Sur's.
The two have swapped places 2 times across 5 shared years of data; in 2010 it was Montenegro ahead.
Montenegro ranks 1st and Sur ranks 2nd of 144 countries.
Montenegro has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Montenegro | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 52.7% | 47.3% | Montenegro |
| 2020s | 75.0% | 72.5% | 2.5% | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Montenegro or Sur?
- Montenegro, at 100.0% against 82.0% in Sur as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Montenegro and Sur?
- 18.0%, with Montenegro ahead.
- How many years of comparable data are there for Montenegro and Sur?
- 5 years are reported by both, from 2010 to 2023.
- How do Montenegro and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Montenegro ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.